Haegarda pharmaceutical
Ended Awarded
- Contract number
- 36C25821N0122
- Awardee
-
CSL Behring L.L.C. UEI H3WKVE9VBLY3
- Awarding agency
-
Veterans Integrated Service Network 22
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $153,282
Award facts
- Contract value 100% obligated
- $153,282.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- King of Prussia, PA 19406, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs Veterans Health Administration, through its Veterans Integrated Service Network 22, awarded a $153,282.20 firm fixed-price delivery order to CSL Behring L.L.C. for the Hereditary Angioedema treatment HAEGARDA. This order was placed against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract with the General Services Administration, which allows federal agencies to efficiently procure pharmaceuticals through task orders. The contract has no set-aside designation, and the place of performance is CSL Behring's location in King of Prussia, Pennsylvania. CSL Behring, a global biotherapeutics company, has previously provided specialty pharmaceuticals such as HAEGARDA and Privigen to support healthcare programs for veterans through prime federal contract awards with the Department of Veterans Affairs and its regional service networks.
Quick answers
Who was awarded contract 36C25821N0122?
36C25821N0122 was awarded to CSL Behring L.L.C. by Veterans Integrated Service Network 22 (Veterans Health Administration) on November 17, 2020.
How much is contract 36C25821N0122 worth?
The government has obligated $153,282 on 36C25821N0122.
Is contract 36C25821N0122 an order under another contract?
Yes. 36C25821N0122 is a delivery order under V797D50358, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25821N0122 competed?
The extent of competition for 36C25821N0122 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award